NVO - NOVO NORDISK A S

QQQ $ 474.01 $ -6.22 (-1.3 %)

DIA $ 394.05 $ 2.64 (0.67 %)

SPY $ 542.74 $ -1.77 (-0.33 %)

TLT $ 94.32 $ 0.38 (0.4 %)

GLD $ 215.63 $ 0.85 (0.4 %)

Previous Close

$ 142.28

Open

$ 141.84

Bid

$ 0.00 x 0

Ask

$ 0.00 x 0

Day's Range

$ 141.57 - $ 142.62

52 Week Range

$ 74.66 - $ 144.50

Volume

2,563,820

Average Volume

Market Cap

641,683

Beta (5Y Monthly)

$ 0.64

PE Ratio (TTM)

$ 0.00

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.01)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type	Report Link
No Data found

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

wegovy-ozempic-maker-novo-nordisk-to-invest-41b-in-us-manufacturing-doubling-plant-size-to-meet-surging-demand-for-weight-loss-drugs

Wegovy, Ozempic Maker Novo Nordisk To Inve...
06/25/2024 04:41:24

Novo Nordisk A/S is set to invest $4.1 billion in expanding its U.S. manufacturing operations to meet the increasing demand for...

U.S. Senate Health Committee Chairman Sand...
06/24/2024 19:15:35

- Reuters

regeneron-pharmaceuticals-approach-to-improve-quality-of-weight-loss-has-merit-goldman-sachs

Regeneron Pharmaceuticals' Approach To Imp...
06/24/2024 18:36:01

Regeneron Pharmaceuticals released data from a Phase 1 study on garetosmab and trevogrumab at the ADA meeting, showing signific...

Novo Nordisk To Invest $4.1 Billion In Nor...
06/24/2024 18:16:34

- Bloomberg Citing Emailed Statement

will-novo-nordisk-building-fires-serve-as-a-catalyst-for-eli-lilly-redditors-see-a-stock-split-for-us-company-very-likely

Will Novo Nordisk Building Fires Serve As ...
06/24/2024 18:08:51

Eli Lilly's stock may rise due to supply issues at competitor Novo Nordisk, according to Reddit users. Its weight loss drug...

Novo Nordisk's Ozempic (Semaglutide) 1mg S...
06/24/2024 17:35:47

Label Extension Application Accepted For FDA Review; Demonstrates Superiority Over Placebo For All Secondary Outcomes; Fewer Se...

China's Medical Products Authority Approve...
06/24/2024 12:57:09

CORRECTION: Novo Nordisk Ticker is "NVO"
06/24/2024 12:56:41

novo-nordisks-wegovy-demonstrates-greater-weight-loss-in-women-with-heart-condition

Novo Nordisk's Wegovy Demonstrates Greater...
06/24/2024 07:17:42

The greater weight loss in women did not result in significantly better improvements in heart failure symptoms.

'House panel weighs new plan for Medicare ...
06/21/2024 18:42:14

https://www.statnews.com/2024/06/21/medicare-coverage-wegovy-weight-loss-cancer-blood-tests-grail/

gilead-sciences-faces-wall-street-speculation-about-obesity-drugs-despite-focus-on-liver-treatments

Gilead Sciences Faces Wall Street Speculat...
06/21/2024 15:42:22

Gilead Sciences faces Wall Street speculation about its potential in the obesity drug market despite its focus on liver treatme...

move-aside-ozempic-wegovy-denmarks-new-drug-just-showed-positive-results-for-weightloss

Move Aside Ozempic, WeGovy: Denmark's New ...
06/21/2024 12:12:28

As per the official press release, the 16-week trial aimed to evaluate the safety, tolerability, and clinical effects of the dr...

nestle-carefully-targets-weight-loss-drug-users-with-new-food-line

Nestle Carefully Targets Weight-Loss Drug ...
06/21/2024 10:18:15

Nestle's new Vital Pursuit brand targets individuals on weight-loss drugs without mentioning medications on packaging, addr...

german-drug-developer-evotec-seeks-adviser-input-as-takeover-concerns-mount

German Drug Developer Evotec Seeks Adviser...
06/20/2024 17:46:42

Evotec consults defense advisers following a significant share price decline, raising concerns about a potential takeover.

Cantor Fitzgerald Reiterates Overweight on...
06/20/2024 17:02:36

Cantor Fitzgerald analyst Louise Chen reiterates Novo Nordisk (NYSE:NVO) with a Overweight and maintains $160 price target.

eli-lilly-expands-fight-against-counterfeit-obesity-drug-zepbound-with-new-legal-actions

Eli Lilly Expands Fight Against Counterfei...
06/20/2024 11:44:10

Eli Lilly & Co has intensified its fight against counterfeit versions of its popular obesity drug, Zepbound, by initiating ...

3-mega-cap-stock-bargains-as-markets-hit-all-time-highs

3 Mega Cap Stock Bargains As Markets Hit A...
06/18/2024 18:51:38

We ran a screener using Benzinga Pro to filter out three mega-cap stocks that are currently trading at attractive valuations.

obesity-in-children---us-parents-face-tough-time-to-access-recommended-treatment-though-novo-nordisks-drug-still-sees-strong-demand

Obesity In Children - US Parents Face Toug...
06/18/2024 16:30:30

U.S. parents face significant barriers to accessing intensive behavioral counseling for childhood obesity, with programs often ...

Novo Nordisk Confirms Fire In Rented Build...
06/18/2024 14:20:16

- Bloomberg Citing Emailed Statement

Cantor Fitzgerald Reiterates Overweight on...
06/17/2024 17:25:26

Cantor Fitzgerald analyst Louise Chen reiterates Novo Nordisk (NYSE:NVO) with a Overweight and maintains $160 price target.

CLASS ACTION DEADLINES - JOIN NOW!

06/28/2024 Malibu Boats, Inc. (MBUU)

07/01/2024 Globe Life Inc. f/k/a Torchmark Corporation (GL)

07/01/2024 Equinix, Inc. (EQIX)

07/02/2024 Intel Corporation (INTC)

07/05/2024 AXT, Inc. (AXTI)

07/05/2024 Altimmune, Inc. (ALT)

07/09/2024 Li Auto Inc. (LI)

07/12/2024 Inari Medical, Inc. (NARI)

07/12/2024 Sprout Social, Inc. (SPT)

07/15/2024 UnitedHealth Group Inc. (UNH)

NEW CASE INVESTIGATION

AnaptysBio Inc (ANAB)

NVONOVO NORDISK A S

NYSE novonordisk.com

$ 142.29 $ 0.32 (0.23 %)

Monday, 24-Jun-2024 15:59:50 EDT